HV

Human Vaccines & Immunotherapeutics

Human Vaccines & Immunotherapeutics is an international open access peer-reviewed journal focused on human vaccinology and immunotherapy. It publishes research on novel vaccines and immunotherapeutics, preclinical studies, clinical trials, disease mechanisms, licensed products, vaccine acceptance and hesitancy, policy, safety, surveillance, epidemiology, pharmaco-economics, and related public health topics. The journal operates single-anonymized peer review, is affiliated with the International Society for Vaccines and the Association for Cancer Immunotherapy, and has been fully open access since Volume 18 in 2022.

Looking to publish in Human Vaccines & Immunotherapeutics? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Immunology
Impact Factor 3.5
Quartile Q2
Open Access Type Open
ISSN 2164-5515
eISSN 2164-554X
Invitation Only No
Cost Range Open access costs may be covered by a Taylor & Francis open access agreement; use the open access cost finder for journal-specific charges.

Submission Instructions

Human Vaccines & Immunotherapeutics accepts the following article types. Click on an article type to view submission instructions.

Research Articles

Cover Letter Cover Letter requirements are not specified.
Abstract Research Articles must include an abstract. The abstract must be 250 words. The abstract must be unstructured.
Manuscript Research Articles must be no more than 5,000 words. Research Articles must be arranged in the order Title page, Abstract, Keywords, Introduction, Patients/Materials and Methods, Results, Discussion, Conclusions, Funding Statement, Acknowledgments, Declaration of Interest Statement, Data Availability Statement, References, Appendices as appropriate, Tables with captions on individual pages, Figures, and Figure captions as a list. Research Articles must include 5 to 10 keywords and a statement disclosing whether and how generative AI was used in the research and manuscript preparation process, or state that generative AI was not used.
References In-text citations must use superscripted numbered references. References must be numbered consecutively in order of first citation, use surname-first author names with initials without periods or spaces, list up to ten authors before using et al., and include a corresponding in-text citation for every entry.
Figures & Tables Figures and tables may be placed within the text or submitted as separate documents, but Research Articles must place tables with captions on individual pages and include figures followed by a separate list of figure captions in the manuscript order. Tables must be supplied as editable files and figures must be relevant and valuable to the work reported.
Reformat to Human Vaccines & Immunotherapeutics using Livewrite Premium

Review Article

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required. Abstract must be 150 words. Abstract must be unstructured.
Manuscript Manuscript must be no more than 8,000 words. Manuscript must be ordered as Title page, Abstract, Keywords, Introduction, Discussion, Conclusions, Funding Statement, Acknowledgments, Declaration of Interest Statement, Data Availability Statement, References, Appendices as appropriate, Table(s) with caption(s) on individual pages, Figures, and Figure captions as a list. Manuscript must include 5 to 10 keywords and a statement disclosing whether and how generative AI was used, or stating that generative AI was not used.
References References must use a numbered citation style with superscripted in-text citations. References must be numbered consecutively in order of first citation, not repeated in the reference list, and entries with more than ten authors must list the first ten authors followed by "et al.".
Figures & Tables Tables with captions must appear on individual pages followed by figures and a separate list of figure captions, and figures and tables may also be placed within the text or submitted as separate documents. Tables must be supplied as editable files.
Reformat to Human Vaccines & Immunotherapeutics using Livewrite Premium

State-Of-The-Art Reviews

Cover Letter Cover Letter requirements are not specified.
Abstract An unstructured abstract is required for State-Of-The-Art Reviews. The abstract must be 150 words. The abstract must be unstructured.
Manuscript The manuscript must be no more than 8,000 words. The manuscript must be ordered as Title page, Abstract, Keywords, Introduction, Discussion, Conclusions, Funding Statement, Acknowledgments, Declaration of Interest Statement, Data Availability Statement, References, Appendices as appropriate, tables with captions on individual pages, figures, and a list of figure captions. The manuscript must include 5 to 10 keywords and a statement disclosing whether and how generative AI was used, or stating that generative AI was not used.
References References must be numbered consecutively in order of first citation and cited in the text using superscripted digits.
Figures & Tables Figures and tables may be placed within the text or submitted as separate documents. Tables must be provided with captions on individual pages, and figure captions must be supplied as a list.
Reformat to Human Vaccines & Immunotherapeutics using Livewrite Premium

Case Report

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required. Abstract must be 150 words. Abstract must be unstructured.
Manuscript Manuscript must be between 1000 and 2000 words. Manuscript must be ordered as Title page, Abstract, Keywords, Introduction, Patients/Materials and Methods, Results, Discussion, Conclusions, Funding Statement, Acknowledgments, Declaration of Interest Statement, Data Availability Statement, References, Appendices as appropriate, Table(s) with caption(s) on individual pages, Figures, and Figure captions as a list. Manuscript must include 5 to 10 keywords and a statement disclosing whether and how generative AI was used in the research and manuscript preparation process.
References References must use consistent scholarly formatting, include complete bibliographic details and corresponding in-text citations, and be numbered consecutively in order of first citation with superscripted digits used for in-text citations.
Figures & Tables Tables with captions must appear on individual pages followed by figures and a list of figure captions, and figures and tables may also be placed within the text or submitted as separate documents. Tables must be supplied as editable files.
Reformat to Human Vaccines & Immunotherapeutics using Livewrite Premium

Rapid Communication

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required. Abstract must be 200 words. Abstract must be unstructured.
Manuscript Manuscript must be no more than 3,000 words. Manuscript must be ordered as Title page, Abstract, Keywords, Introduction, Patients/Materials and Methods, Results, Discussion, Conclusions, Funding Statement, Acknowledgments, Declaration of Interest Statement, Data Availability Statement, References, Appendices as appropriate, Table(s) with caption(s) on individual pages, Figures, and Figure captions as a list. Manuscript must include 5 to 10 keywords and a statement disclosing whether and how generative AI was used in the research and manuscript preparation process.
References References must be numbered consecutively in order of first citation with in-text citations given as superscripted digits, and entries with more than ten authors must list the first ten followed by et al.
Figures & Tables A combined total of tables and figures must not exceed 4. Tables with captions must appear on individual pages, followed by figures and then a list of figure captions.
Reformat to Human Vaccines & Immunotherapeutics using Livewrite Premium

Mini-Reviews

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Mini-Reviews must be no more than 3,000 words. The manuscript must include a statement disclosing whether and how generative AI was used in the research and manuscript preparation process.
References References must be numbered consecutively in order of first citation and cited in the text using superscripted digits.
Figures & Tables Figures and tables may be placed within the text or submitted as separate documents.
Reformat to Human Vaccines & Immunotherapeutics using Livewrite Premium

Recent Publications

Premature mortality and years of potential productive life lost due to HPV-attributable cancers in Brazil and Mexico: 2011 Versus 2023

Paula Cristina Pungartnik, Cintia Irene Parellada, Daniela Mayumi Usuda Prado Rocha, Rodrigo Gonçalves Queijo, Ana Luiza Bierrenbach, Juan Carlos Orengo

10.1080/21645515.2026.2728247
View Publication

Sintilimab‑related cystitis/ureteritis in high‑grade endometrial stromal sarcoma: A case report and structured literature review

Shuhan Yang, Ruike Gao, Daorui Li, Wenguang Shi, Xuedong Yang, Peiqi Shi, Leilei Qi, Weina Li, Ying Zhang, Jie Li

10.1080/21645515.2026.2707681
View Publication

5C psychological antecedents of vaccine hesitancy toward maternal RSV vaccines and infant monoclonal antibodies among pregnant and postpartum women and their partners in China: A multicenter, dyadic survey design, cross-sectional study

Yixiao Zhu, Jing Wu, Leying Hou, Xinyu Liu, Xuan Zhu, Wei Xia, Na Wang, Yang Zhao, Guanlan Zhao, Peige Song

10.1080/21645515.2026.2716519
View Publication

Projected epidemiological impact of lowering the adult pneumococcal vaccination age from 60 to 50 years in Germany

Oluwaseun Sharomi, Marion de Lepper, Lisa M. Lang, Thorsten Reuter, Claudia Solleder, Giulio Meleleo, Tufail Malik, Kevin M. Bakker, John C. Lang, Rachel J. Oidtman

10.1080/21645515.2026.2709836
View Publication

Parents’ and caregivers’ views on pediatric meningococcal disease and serogroup B vaccination

Oscar Herrera-Restrepo, Vasudha Gupta, Sophie Jacobovitz, Tosin Olaiya, Elise Kuylen, Karam Dahyaleh, Lynn Kwock, Thatiana Pinto, Sofia B. Pinto, Suzanne Staebler

10.1080/21645515.2026.2720966
View Publication

Frequently asked questions

How long does it take to publish?

25 days average from submission to first decision; 48 days average from submission to first post-review decision; 14 days average from acceptance to online publication.

Reformat to Human Vaccines & Immunotherapeutics using Livewrite Premium

Is a cover letter required?

A cover letter is not used for APC waiver requests. Waiver requests must be made at the time of online submission, not in a cover letter.

Reformat to Human Vaccines & Immunotherapeutics using Livewrite Premium

What are the publication costs?

Open access costs may be covered by a Taylor & Francis open access agreement; journal-specific charges vary.

Reformat to Human Vaccines & Immunotherapeutics using Livewrite Premium

Research Topics

Vaccine Coverage and Hesitancy Influenza Virus Research Studies SARS-CoV-2 and COVID-19 Research Hepatitis B Virus Studies Respiratory viral infections research Pneumonia and Respiratory Infections Immunotherapy and Immune Responses Cervical Cancer and HPV Research Viral gastroenteritis research and epidemiology Bacterial Infections and Vaccines Hepatitis Viruses Studies and Epidemiology Virology and Viral Diseases COVID-19 epidemiological studies Herpesvirus Infections and Treatments Immune responses and vaccinations Cancer Immunotherapy and Biomarkers Viral Infections and Immunology Research vaccines and immunoinformatics approaches Viral Infections and Outbreaks Research Misinformation and Its Impacts Animal Virus Infections Studies Immune Cell Function and Interaction COVID-19 Clinical Research Studies CAR-T cell therapy research Immune Response and Inflammation

Related Journals

JO
Journal of Allergy and Clinical Immunology Elsevier BV
SA
Science and Medicine in Football Taylor & Francis
JO
Journal of Translational Autoimmunity Elsevier BV
IR
International Review of Psychiatry Taylor & Francis
JF
Journal for ImmunoTherapy of Cancer BMJ
JO
Journal of Investigative Surgery Taylor & Francis